-
Carbone KM, Wolinsky JS (2001) Mumps Virus. In: Fields BN, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, Knipe DM (eds) Fields-virology, vol 4. pp 1381-1400
-
Carr MJ, Moss E, Waters A, Dean J, Jin L, Coughlan S, Connell J, Hall WW, Hassan J, 2010: Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland[J]. J Clin Microbiol, 48, 3288-3294. doi: 10.1128/JCM.00434-10
-
Cui A, Zhu Z, Chen M, Zheng H, Liu L, Wang Y, Ma Y, Wang C, Fang X, Li P, Guan R, Wang S, Zhou J, Zheng L, Gao H, Ding Z, Li L, Bo F, Sun Z, Zhang Z, Feng D, He J, Chen H, Jin L, Rota PA, Xu W, 2014: Epidemiologic and genetic characteristics of mumps viruses isolated in China from 1995 to 2010[J]. Infect Genet Evol, 21, 384-390. doi: 10.1016/j.meegid.2013.12.005
-
Cui A, Zhu Z, Hu Y, Deng X, Sun Z, Zhang Y, Mao N, Xu S, Fang X, Gao H, Si Y, Lei Y, Zheng H, He J, Wu H, Xu W (2017) Mumps epidemiology and mumps virus genotypes circulating in mainland China during 2013-2015. PLoS ONE 12: e0169561
-
Cui A, Zhu Z, Zhang Y, Qiu Q, Mao N, XU S, Ji Y, Wang H, Xu W, 2018: Viral surveillance and genetic characteristics of mumps viruses in China during 2001-2017[J]. Chin J Vacc Immun, 24, 249-255.
-
Dayan GH, Rubin S, 2008: Mumps outbreaks in vaccinated populations:are available mumps vaccines effective enough to prevent outbreaks?[J]. Clin Infect Dis, 47, 1458-1467. doi: 10.1086/591196
-
Iabs (2006) IABs scientific workshop on neurovirulence tests for live virus vaccines, January 31-February 1, 2005, Geneva. Biologicals 34: 233-236
-
Park SH, 2015: Resurgence of mumps in Korea[J]. Infect Chemother, 47, 1-11. doi: 10.3947/ic.2015.47.1.1
-
Rubin SA, Afzal MA, 2011: Neurovirulence safety testing of mumps vaccines-historical perspective and current status[J]. Vaccine, 29, 2850-2855. doi: 10.1016/j.vaccine.2011.02.005
-
Rubin SA, Pletnikov M, Carbone KM, 1998: Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain[J]. J Virol, 72, 8037-8042. doi: 10.1128/JVI.72.10.8037-8042.1998
-
Rubin SA, Pletnikov M, Taffs R, Snoy PJ, Kobasa D, Brown EG, Wright KE, Carbone KM, 2000: Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans[J]. J Virol, 74, 5382-5384. doi: 10.1128/JVI.74.11.5382-5384.2000
-
Sauder CJ, Vandenburgh KM, Iskow RC, Malik T, Carbone KM, Rubin SA, 2006: Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity[J]. Virology, 350, 48-57. doi: 10.1016/j.virol.2006.01.035
-
Turner PC, Forsey T, Minor PD (1991) Comparison of the nucleotide sequence of the SH gene and flanking regions of mumps vaccine virus (Urabe strain) grown on different substrates and isolated from vaccinees. J Gen Virol 72(Pt 2): 435-437
-
WHO (2012) Weekly epidemiological record relevé épidémiologique hebdomadaire 29: 241-248
-
Xu P, Luthra P, Li Z, Fuentes S, D'Andrea JA, Wu J, Rubin S, Rota PA, He B, 2012: The V protein of mumps virus plays a critical role in pathogenesis[J]. J Virol, 86, 1768-1776. doi: 10.1128/JVI.06019-11
-
Zengel J, Phan SI, Pickar A, Xu P, He B (2017) Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China. Vaccine 35: 3988-3994